Decreased practice effects in preclinical Alzheimer’s disease: a multicenter, longitudinal, cohort study

Individuals with normal cognition who are in the Alzheimer's continuum show decreased practice effects over serial neuropsychological testing. Our findings suggest the reduction of practice effects, particularly in memory measures, as an indicator of subtle cognitive decline in the earliest phase of the Alzheimer's continuum and could be particularly relevant for the design and interpretation of primary prevention trials on disease-modifying therapies.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.087332
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Decreased practice effects in preclinical Alzheimer’s disease: a multicenter, longitudinal, cohort study

Sara Rubio‐Guerra, Juan Fortea, Mirian Ecay‐Torres, Alberto Lleó et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Decreased practice effects in preclinical Alzheimer’s disease: a multicenter, longitudinal, cohort study

Sara Rubio‐Guerra, Juan Fortea, Mirian Ecay‐Torres, Alberto Lleó, Ana Pozueta, Ainara Estanga, María Araceli García Martínez, Agnès Pérez‐Millan, Núria Guillén, Albert Lladó, Eloy Rodríguez‐Rodríguez, Jordi Sarto, Lorena Rami, Bea Bosch, Jordi Juncà‐Parella, Mircea Balasa, Miren Altuna, Raquel Sánchez‐Valle, Adrià Tort‐Merino, Ignacio Illán‐Gala, Pablo Martínez‐Lage, Sergi Borrego‐Écija, Nuole Zhu, Pascual Sánchez‐Juan, Diana Esteller, Guadalupe Fernández‐Villullas, Mikel Tainta, Andrea Val‐Guardiola, Magdalena Castellví, Carolina López, Neus Falgàs Martínez, Anna Antonell, Ma Belén Sánchez‐Saudinós
article en

Abstract

Individuals with normal cognition who are in the Alzheimer's continuum show decreased practice effects over serial neuropsychological testing. Our findings suggest the reduction of practice effects, particularly in memory measures, as an indicator of subtle cognitive decline in the earliest phase of the Alzheimer's continuum and could be particularly relevant for the design and interpretation of primary prevention trials on disease-modifying therapies.

Alzheimer s & DementiaVol. 20(S3)
Universitat Autònoma de Barcelona (ES), Universidad de Cantabria (ES), Universidad de Deusto (ES), Hospital de Sant Pau (ES), Marqués de Valdecilla University Hospital (ES), Instituto de Investigación Marqués de Valdecilla (ES), Centro de Investigación Biomédica en Red (ES), Hospital Clínic de Barcelona (ES), Osakidetza (ES), Fundacion CITA Alzheimer (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Institut de Recerca Sant Pau (ES), Universitat de Barcelona (ES)
Quality Education
Openalex Percentile: Top 66%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.